Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
26 mrt 2007 - 08:29
Statutaire naam
Crucell N.V.
Titel
DSM Biologics and Crucell Announce PER.C6® Licensing Deal with Taiwanese Development Center for Biotechnology
Bericht
Sittard/Leiden, The Netherlands, March 26, 2007 – DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX), today announced that they have signed a non-exclusive PER.C6® research licensing deal with Taipei, Taiwan-headquartered Development Center for Biotechnology (DCB
Gerelateerde downloads
Datum laatste update: 01 september 2024